Table 2 Parameters of haematologic data, CGMs and T-TAS before and after glycemic control in STUDY 1
| Â | Baseline | After control | P-value |
|---|---|---|---|
FPG (mM) | 9.6 ± 2.3 | 6.3 ± 1.4 | 0.004 |
Hematologic parameters | |||
 WBC count (/μL) | 5752 ± 1440 | 5468 ± 1342 | 0.191 |
 Ht (%) | 41.1 ± 4.8 | 40.7 ± 4.9 | 0.523 |
 Plt count (104 /μL) | 19.3 (16.6–24.2) | 20.2 (18.9–24.1) | 0.683 |
 PAI-1 (ng/mL) | 24.0 (16.3–45.3) | 21.0 (14.5–28.5) | 0.211 |
 Fibrinogen (g/dL) | 3.3 ± 0.7 | 3.6 ± 0.3 | 0.128 |
 Factor VII (%) | 85.4 ± 8.6 | 83.6 ± 11.2 | 0.522 |
 Factor VIII (%) | 101.1 ± 33.4 | 92.3 ± 28.7 | 0.288 |
 F1 + 2 (pM) | 135.5 (105.0–169.3) | 139.5 (107.3–173.5) | 0.580 |
CGMs | |||
 Mean PG (mM) | 10.1 ± 2.5 | 6.8 ± 0.9 | 0.005 |
 Peak PG (mM) | 16.3 (11.3–19.1) | 10.2 (8.8–12.4) | 0.017 |
 SD (mM) | 1.8 (1.2–2.4) | 1.1 (0.9–1.7) | 0.242 |
 MAGE (mM) | 4.3 (2.9–7.0) | 2.8 (2.2–4.1) | 0.310 |
T-TAS | |||
 PL-T10 (s) | 125.5 (110.8–141.0) | 126.0 (120.5–135.3) | 0.881 |
 PL-OT (s) | 327.8 ± 67.6 | 308.7 ± 56.5 | 0.166 |
 PL-AUC10 (kPa × min) | 393.2 ± 45.3 | 398.3 ± 32.2 | 0.647 |